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Carboxymethylcellulose (CMC)/chitosan microparticles containing
vitamin E were prepared by a complex coacervation method and
their potential use as a topical delivery system was evaluated.
Morphology, particle size distribution, encapsulation yield, physical
and chemical stability, in vitro release and permeation through
skin were studied. The microparticles appeared to be spherical,
with a homogeneous surface and were not aggregated. Mean
diameters ranged from 2.7 to 7.6 μm and the encapsulation yield
was 81%. Chemical stability studies indicated a protection of
encapsulated vitamin E, of 8.1% for O/W and of 10.83% for W/O
emulsions, following storage at 45 °C for 60 days. Forty-eight%
of vitamin E, determined by HPLC, were released within 24 hours.
In vitro permeation and retention studies showed a higher
penetration rate of vitamin E in the free and encapsulated forms,
from the W/O emulsion. The carriers studied seem to be promising
systems for topical administration.
INTRODUCTION
One of the biggest challenges to Pharmaceutical
Sciences over the last 40 years has been finding new ways
to extend the releasing capacity of active compounds from
delivery systems (Kydoneus, Berner, 1987).
Cutaneous administration, leading to the release of
active substances on the epidermis, coupled to their
maintenance at the site of action, is a new research area.
Improved delivery systems maximizing the time of
permanence of active compounds on the skin by
minimizing transdermal absorption may play an
important role in the success of this therapy (Embril,
Nacht, 1996).
Active compounds such as UV fi l ters  and
antiseptics should remain on the skin surface to
effectively perform their functions. Other active
substances such as antioxidants,  whitening and
antiaging agents can be effective on the epidermis or
dermis (Morganti et al . ,  2001). In recent years,
microparticles have aroused increasing interest as
drug delivery systems. Many authors reported that
micropart ic les  could be used to  del iver  act ive
compounds into the skin in greater amounts than do
conventional topical formulations, with improved
localization at the desired site of action. Natural or
synthetic polymers can be used for the obtention of
microparticles. Among the polymers available for
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microencapsulation purposes, chitosan has been
widely studied as means of obtaining long-term,
susta ined drug re lease  f rom micropar t ic le
prepara t ions  showing biocompat ib i l i ty  and
biodegradability. Clinical tests have not reported
al lergic  or  inf lammatory react ions  fo l lowing
implantat ion,  inject ion,  topical  appl icat ion or
ingestion of such preparations (Muzzarelli, 1995).
Interest has focused on the use of vitamin E, a natu-
ral antioxidant with important biological effects, in topical
administration carriers. When used in skin care products,
the vitamin protects this tissue from the effects of UV
radiation, delays the photoaging process and exhibits
moisturizing properties. In order to obtain a moisturizing
effect, vitamin E must be absorbed and kept on the skin at
a certain concentration. Its exact moisturizing mechanism
is not completely known yet; it may be the consequence of
the vitamin’s marked antioxidant character. An effective
free radical capture agent, vitamin E can be able to prevent
and repair skin damage in aggressive situations. This
effect may enable the skin to use its own moisture control
system via natural humectant factors and adequate lipid
barriers (Tamburic et al., 2000).
Vitamin E is slowly oxidized by atmospheric
oxygen, via a reaction catalyzed by light and heat in the
presence of silver salts and iron (Handbook of Vitamins
1991; The Merck Index, 1996).
The aim of this work was to evaluate carboxymethyl-
cellulose/chitosan vitamin E microparticles as a skin delivery
system. To study this effect, scanning electron microscopy
(SEM), particle size distribution, physical-chemical stability,
in vitro release and permeation were used.
MATERIALS AND METHODS
Vitamin E microparticles (Primaspheres®), batch
number G26F05, were prepared and supplied by Cognis
Brasil Ltda.The solvents for analytical analysis were of
chromatography grade and were purchased from Merck
(Darmstadt, Germany). All others chemicals were of
reagent grade, obtained from Merck (Darmstadt, Germany).
Microparticles preparation
The production technique used was the complex
coacervation (Patent: WO/PCT/EP01/01177). Initially, an
O/W emulsion was obtained containing the active
substance (vitamin E). Then, the cationic polymer
chitosan of the aqueous phase was forced to precipitate in
the interphase by the interaction with the anionic polymer,
carboxymethylcellulose (CMC).
Measurement of particle size
The particle size distribution analysis was carried out
by laser diffraction, using a CILAS 1064 Granulometer.
Scanning electron microscopy
Particle morphology was examined by Scanning
Electron Microscopy (SEM), using a Leica-Stereoscan
440 equipment. Samples were dried at 37 °C for 24 hours
and prior to visualization, covered with gold using a
Spulter Balzers SCD 050 Coater .
Drug loading determination
Encapsulation efficiency was determined by an indirect
method (Calvo et al.,  1997; Cui, Mumper, 2001).
Microparticle dispersions containing 250 mg/mL of vitamin E
were prepared in phosphate buffer (pH = 7.2) containing 2 mM
polysorbate 80. Aliquots were filtered through 0.45 mm pore
membranes; the amount of vitamin E present in the filtrate (free
vitamin E) was assayed by HPLC. The total amount of the
vitamin present in the preparation was determined after
extraction with methanol, followed by ultra- sonication for 30
minutes in order to break up the particles, followed by filtration
and posterior assay by HPLC. Encapsulation efficiency (drug
loading) was calculated as follows:
Drug loading = total % vitamin E - free % vitamin E
Vehicle formulations
The composition of the emulsions used in this study
is presented in Tables I and II.
After the emulsification process the equivalent to
0.25% of free or encapsulated form (microparticles) of
vitamin E was added to O/W and W/O emulsions, under
slow agitation.
Stability studies
Samples of the O/W or W/O emulsions containing
free or encapsulated vitamin E were stored at different
temperatures (5, 25 and 45 °C) for a 2-month period and
its macroscopic appearance examined at regular intervals
(Cannel, 1985; Cadwallader, 1989; Idson, 1993;
International Conference On Harmonization, 2003).
The chemical stability of the emulsions was
evaluated by quantification of vitamin E remaining in the
stored formulations by HPLC. The assay was performed
in triplicate.
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HPLC assay
Chromatographic analysis were carried out in a
Shimadzu chromatograph, model SPD, equipped with an
UV detector operating at 290 nm, a LC-ADVP pump, a
Rheodyne injector and a CR-6 integrator. The separation
was carried out in a Lichrosphere 100 RP - 18 (125 x 4 mm
(5 mm) column, Merck), protected by a RP-18 guard
column (4x4 mm, Merck). Elution was performed at
controlled room temperature (25 ± 1 °C), at flow- rate of
1 mL/min, with a mobile phase consisting of a methanol:
water mixture (99:1), an injection volume corresponding
to 20 µL except for the release and permeation tests in
which a volume of 200 µL was used .
Precision, accuracy, quantification limit, selectivity
and recovery data were determined in order to validate the
chromatographic method.
The precision and accuracy of the method were tested
by within day (intra-assay) and between day (inter-assay)
analyses. For the determination of intra-assay precision and
accuracy, aliquots (n=10) of a vitamin E methanol solution,
at concentrations of 0.5 and 50.0 µg/mL were analyzed as
described above. The precision of the assay was calculated
from the percent coefficient of variation (CV) of the mean.
The accuracy of the assay was calculated from the relative
errors of the means between expected and calculated
concentrations. Inter-assay precision and accuracy were
calculated by analyzing aliquots of the same samples on five
consecutive days.
The sensitivity of detection was considered as the
minimum amount of the drug that could be measured
without interference of the basal line. To assess selectivity,
the receptor medium used in the in vitro skin permeation
experiments was submitted to chromatographic analysis.
In addition, blanks prepared for each (O/W and W/O
without vitamin E) formulation were also analyzed.
In vitro vitamin E release studies
For these studies, dispersions of microparticles in
isotonic phosphate buffer (pH = 7.2), containing 2 mM
polysorbate 80 and 250 µg/mL vitamin E, were maintained
at 37 ° ± 1 °C for 24 hours, under constant stirring, at 100
rpm. At pre- established time intervals (0, 2, 4, 8, 12 and 24
hours), 1 mL of the medium was removed and replaced by an
equal volume of fresh receptor solution. Samples were
filtered through 0.45 mm pore membranes and appropriately
diluted for the determination of their free vitamin E content.
The results refer to the average of six experiments.
In vitro permeation and retention studies
Slices of dorsal skin from 4 to 6-week-old male hairless
mice (strain HRS/ J Jackson Laboratories, Bar Harbor, ME)
were mounted in a diffusion cell system (Microette Hanson
Research Corporation), with their dermal side in contact with
the receptor medium (7 mL of isotonic phosphate buffer pH
= 7.2, containing 2 mM of polysorbate 80). The donor
compartment was filled with 200 mg of the formulations. The
experiments were carried out at 37 oC, with the receptor
medium stirred at 300 rpm. One mL of the medium was
removed after 4, 8, 12 and 24 hours respectively, and assayed
for its vitamin E content. Six experiments were carried for
each formulation. At the end of each experiment, skins were
removed from the diffusion cells, and the excess formulation
TABLE II - Composition of the W/O emulsion
Components %
Phase I
Polyglyceryl dipolyhydroxystearate 3.00
Polyglyceryl diisostearate 3.00
Bee wax 3.00
Zinc stearate 1.00
Dicaprylyl ether 3.00
Coco caprylate/caprate 6.00
Capric/caprylyl triglyceride 8.00
Propyl paraben 0.02
Phase II
Glycerin 5.00
MgSO4•7H2O 1.00
Methyl paraben 0.18
Distilled water up to 100.00
TABLE I - Composition of the O/W emulsion
Components %
Phase I
Cetearyl glucoside and cetearyl alcohol 3.00
Sodium cetearyl sulphate 0.25
Glyceryl stearate 1.50
Capric/caprylyl triglyceride 5.00
Dicaprylyl ether 5.00
Hexyldecanol 2.00
Cyclomethicone 0.50
Propyl paraben 0.02
Phase II
Glycerin 3.00
Methyl paraben 0.18
Distilled water up to 100.00
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carefully removed with distilled water. The tissues were fixed
to a support and submitted to removal of the SC by the tape
stripping method using adhesive tapes (3M®). The tapes were
transferred to a conical tube, 5 mL of methanol (extractor
solvent) were added and the tubes mixed for 3 minutes.
Extracted vitamin E was assayed by HPLC. The remaining
tissue (epidermis + dermis) was cut into fragments and
transferred to conical tubes. One mL of methanol was added
and the tubes sonicated for 30 minutes. Contents were filtered
through 0.45 mm pore membrane filters and the vitamin E
content of the filtrates analyzed.
RESULTS AND DISCUSSION
Pharmaceutical and Cosmetic Technologies have
dedicated special attention to the development and
evaluation of formulations providing controlled release of
active substance(s), taking into consideration that
significant progress could be obtained by the use of
pharmaceutical and cosmetic forms capable of modulating
the release of active compounds and of localizing them at
desired sites of action.
Micro/nanoparticles emerged as one of the most
promising strategies to obtain controlled delivery systems
(Berthold et al., 1998), They have been extensively used
for oral, parenteral and topical administration, as well as
to vehicle many compounds into the skin, including 5-
fluorouracyl (Ghorab et al., 1990), α-tocopherol (Dingler
et al., 1999), glycolic acid (Perugini et al., 2000), retinol
(Jening et al., 2000), some allergenic substances (Brosse
et al., 2000) and others.
In the present study, CMC/chitosan microparticles
presented diameters ranging between 2.726 and 7.654 mm
(Table III). The analysis of the particle size distribution is
important in skin penetration studies since depending on
their size, it becomes possible to forecast the probability
of these particles penetrating the stratum corneum or the
hair follicles, in order to reach viable epidermis and dermis
sites, where vitamin E will develop its biological function.
SEM photomicrographs show that the micro-
particles obtained in this work present spherical shapes
with a smooth and homogeneous surface and a non-
aggregated distribution (Figure 1). Their morphology is of
fundamental importance because it can directly influence
the release and penetration of active substances from the
encapsulated form into the skin.
The epidermal stratum corneum consists mainly of
keratin, ceramides, cholesterol and free fatty acids. These
lipids are distributed in a lamellar structure in the intercellular
spaces (Kumpel et al., 1998; Dietz, Hameyer ,2003).
Madison et al., (1987) achieved the first visualization
of the broad-narrow-broad arrangement of the stratum
corneum intercellular lipid lamellae. It was recognized at
the time that the broad lamellae in the stratum corneum, as
well as the precursor lamellae in the lamellar granules, have
the dimensions (approximately 5 nm) of a typical lipid
bilayer, whereas, the broad-narrow-broad units were 13 nm
wide. This 13 nm periodicity corresponds to the distance
from the center of one pair of bilayers, to the center of the
next pair (Kumpel et al., 1998).
Bronaught et al., 1982, in order to more completely
characterize permeability relationships, measured the
thickness of the stratum corneum, of the epidermis and of
whole skin. He utilized frozen sections of the skin to
overcome the well-known destructive effect of standard
embedding and fixing procedures on the stratum corneum.
Determination of hair follicle density, under the
microscope, demonstrated the average diameter of the hair
follicles of the human abdomen to be of 97 ± 3 mm, and of
those of the dorsal area of the hairless mouse to be of 46 ±
1 mm. Based on this information and on our results of
scanning electron microscopy and particle size distribution,
we concluded that the particles under study should be able
TABLE III – Particle size distribution of vitamin E
microparticles
Population Mean Diameter* Variation
(%)  ± SD (µm) Coefficient (%)
10 0.948 ± 0.004 0.422
50-90 2.726- 7.654 ± 0.106 1.384
 *The results represent the mean diameter of 5 determinations
FIGURE 1 -  Photomicrography of CMC/chitosan
microparticles containing vitamin E.
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to penetrate into the human or mouse skin through hair
follicles or to remain on the stratum corneum surface,
delivering the active substances into the epidermis.
The Tables IV and V show the parameters of
precision, accuracy, quantification limit and recovery
obtained by HPLC method validation.
With the results obtained in the intra- and inter-
assay, it was observed that the method chosen for the
quantitative analyses of vitamin E presented precision,
accuracy, sensitivity and selectivity adequate for the
performance of the proposed studies.
Encapsulation yield was 81%, a satisfactory level,
confirming the suitability of the complex coacervation
method of preparation.
Physical stability studies showed that O/W and W/O
emulsions were stable for a 2-month period, during which
no changes like flocculation, cremeation or coalescence
were observed, indicating that these emulsions can be used
as vehicles for free and microencapsulated vitamin E.
Alpha-tocopherol content in W/O and O/W emulsions
stored at 5 or 25 oC remained practically constant for 60 days.
Samples stored at 45 oC, for 60 days, showed a gradual
decrease of vitamin E due to chemical degradation. A higher
protection of vitamin E encapsulated in microparticles was
noted, of 8.10% and 10.83% in O/W and W/O emulsions,
respectively (Figure 2 and Table VI). Analysis by Student’s
t test showed these results to be statistically different (p<0.05)
from those of formulations containing the free vitamin.
Microparticles obtained using other polymers did not
present significant stability for instable actives, (Rossler et al.,
1994); collagen microparticles containing retinol incor-
porated in hydrogels, did not show a statistically significant
increase of stability compared to formulations containing free
retinol. Microparticles had no influence on the chemical
stability of retinol. Therefore in this respect, CMC/chitosan
microparticles seem to be more efficient.
The pattern of release of vitamin E from CMC/
chitosan microparticles is shown on Figure 3. During the
first stage of dissolution, a “burst effect” occurred  which
increased linearly for up to 12 hours, after which the
vitamin concentration remained constant. Analysis of
these results by linear regression data indicated that
vitamin E release from microparticles, initially followed
pseudo-zero order kinetics (Higuchi, 1963), stabilizing
after 12 hours into a sustained release pattern.
TABLE IV – Precision, accuracy and quantification limit obtained by HPLC
Assay Theoretical Obtained C.V. A
concentration (µg/mL) concentration (µg/mL)
Inter-assay 0.5 00.4892 (± 0.0129) 2.6391 2.1677
50.0 50.1667 (± 1.0432) 2.0795 0.3333
Intra-assay 0.5 00.5091 (± 0.0354) 6.9500 1.8166
50.0 49.3481 (± 1.0418) 2.1111 1.3039
Quantification limit 0.20000 00000000.20069 (± 8.64565 . 103) 04.30801 00.34382
The results represent the mean and the standard deviation of 5 determinations; C.V. = Coefficient of Variation; A =
Accuracy
TABLE V – Results obtained in the test of vitamin E
recovery from O/W and W/O formulations by HPLC
Samples Vitamin E Recovery (%)*
O/W + vitamin E 102.510 ± 1.350
O/W + microparticles 97.730 ± 2.623
W/O + vitamin E 101.295 ± 3.596
W/O + microparticles 99.240 ± 2.220
The data represent the mean of 3 determinations with their
respective standard deviation.
FIGURE 2 - Stability of vitamin E (free and encapsulated
forms) in O/W and W/O formulations, stored at the
temperature of 45 oC, for 60 days. Bars represent standard
deviations of the means of three determinations.
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The results of retention studies presented on Figure
4 show the amounts of vitamin E retained in the stratum
corneum, epidermis + dermis and permeated into the re-
ceptor solution, after a 24 hour-experiment in diffusion
cells. A higher availability of vitamin E incorporated into
W/O emulsions was observed.
This result may be attributed to a higher thermo-
dynamic activity in the W/O emulsions, since both the
distribution coefficient and the concentration of the active
substance depend not only on its total concentration, but also
on its concentration in the solubilizing phase (Forsters et al.,
1997). In discussing the smaller penetration of vitamin E
from O/W emulsions, these authors attributed this fact to the
formation of a lamellar layer, responsible for the viscosity of
these formulations. Such lamellar layers would prevent the
diffusion of vitamin E in the oily phase towards the skin.
The amounts of vitamin E permeated, quantified
after 24 hours, showed a higher permeation in its free form
from the O/W and W/O emulsions.
Wester et al. (1991) compared benzoyl peroxide
absorption by the skin from a topical formulation containing
the active substance dispersed or encapsulated in a system of
microsponges (styrene/divinylbenzene) with a mean
diameter of 25 µm. In vitro studies using human skin showed
that after 24 h, smaller quantities of the active ingredient were
recovered in the epidermis from the encapsulated form (1.1
± 0.7% of the applied dose) in compared to the free form (5.2
± 4.1%). The same result occurred in the dermis. However,
these results were statistically non-significant (p > 0.05). It
was also observed that the amount permeating from the
microsponge formulation was 3.5 ± 3.4% and that from the
free form, 17.1 ± 15.7% .
Dingler et al. (1999) carried out the in vivo
administration of α-tocopherol and α-tocopherol acetate
to 20-30 year old volunteers, using dispersions of
nanoparticles with mean diameters of 280 and 270 nm,
respectively. After 30 minutes of contact with the skin, the
excess of the formulation was eliminated and tape
stripping carried out. The quantity of the two active
ingredients that penetrated the stratum corneum from the
encapsulated preparation was twice that from controls
containing the vitamin in free form.
Perugini et al. (2000) evaluated the potential of three
types of microparticulated systems, respectively:
liposomes, liposomes modified by the addition of chitosan
with diameters from 2-10 µm, and of 2-15 µm diameter
chitosan microspheres, in the transport of glycolic acid, a
small hydrophilic compound. Liposomes were able to
TABLE VI – Percent of vitamin E remaining in formulations stored at 45 OC for 60 days
Time (days) O/W +vitamin E(%) O/W + microparticles(%) W/O +vitamin E(%) W/O + microparticles(%)
0 102.510 ± 1.350 97.730 ± 2.623 101.295 ± 3.596 99.240 ± 2.220
30 84.685 ± 0.285 87.155 ± 1.395 86.755 ± 0.375 88.655 ± 0.165
60 67.750 ± 0.430 75.855 ± 1.755 64.195 ± 1.555 75.030 ± 0.410
*Results represent means of 3 determinations with their respective standard deviations
FIGURE 3 - Vitamin E release from CMC/chitosan
microparticles in phosphate buffer pH=7.2 containing
2 mM polysorbate 80. Bars represent standard derivations
of means of six determinations.
FIGURE 4 - Quantity of vitamin E in the stratum corneum,
epidermis without stratum corneum + dermis and
permeated from the formulations O/W and W/O after 24
hours of experiment carried out in diffusion cells at 37 oC.
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delay the release of glycolic acid, and microspheres were
unable to modulate active substance release even
following crosslinking with glutaraldehyde, a compound
causing a reduction of microsphere sizes.
In previous studies, Genta et al. (1997) were able to
modulate the release of the acyclovir, a lypophilic drug,
using chitosan microspheres with mean diameter ≤ 25 µm
for ocular administration.
Based on the experimental results obtained on the in
vitro release and cutaneous penetration of vitamin E, as well
as on literature data, it can be concluded that the general
releasing properties of active substances from particulate
systems are directly or indirectly related to the following
factors: (i) The presence or absence of macro and
micropores in the particulate system; microsponges (Wester
et al., 1991) and nylon particles (Parison, 1993) as typical
examples of porous systems; (ii) particle size, with
nanoparticles presenting a higher probability of penetrating
the stratum corneum, while larger particles (microparticles,
diameters > 1 µm) are retained on the skin surface or
penetrate via hair follicles; (iii) intrinsic characteristics of
delivery systems being directly related to the process and
materials used for their manufacture; indirect factors related
to (iv), the carrier into which the delivery system is
incorporated; (v) intrinsic characteristics of the active
substance to be encapsulated; and (vi) depending on the
characteristics of active substance and carrier, different
release behaviors may be expected, since after release from
particulated systems, active substances have to diffuse
through barrier(s) to reach their site(s) of action.
To conclude: in view of adequate morphology, particle
size, sustained release profile and skin penetration behaviour,
CMC/chitosan microparticles prepared by complex
coacervation may become promising systems for the topical
delivery of various therapeutically active compounds.
RESUMO
Estudo das características e propriedades da permeação
in vitro de micropartículas de CMC/quitosana como
sitema de liberação cutânea para vitamina E
Micropartículas de carboximetilcelulose (CMC)/quitosana
contendo vitamina E foram preparadas pelo método de
coacervação complexa e seu uso potencial como um siste-
ma de liberação tópico foi avaliado. Estudos da
morfologia, da distribuição do tamanho de partículas, da
eficiência de encapsulação, da estabilidade física e química
e da liberação e permeação cutânea in vitro foram realiza-
dos. As análises por Microscopia Eletrônica de Varredura
mostraram que as partículas são esféricas, possuem uma
superfície homogênea e ausência de agregados, com diâ-
metros na faixa de 2,7 a 7,6 μm. A eficiência de encap-
sulação da vitamina E foi 81%. Os estudos de estabilidade
química mostraram proteção da vitamina E encapsulada,
sendo que a diferença em relação à quantidade de ativo re-
manescente na emulsão O/A foi de 8,1% e na A/O, de
10,8%, após armazenamento a 45 °C por um período de 60
dias. O ensaio de liberação in vitro mostrou que 48% da vi-
tamina E encapsulada, quantificada por CLAE, foram libe-
radas em 24 horas de experimento. Nos estudos de retenção
e permeação in vitro observou-se que a emulsão A/O pro-
porcionou maior penetração da vitamina E tanto da forma
livre como encapsulada.Os sistemas avaliados parecem ser
promissores para veiculação de ativos em preparações de
uso tópico.
UNITERMOS: Micropartículas. Quitosana. Vitamina E.
Permeação cutânea in vitro
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